Smith & Nephew Seeks UK Approval for Bone Device

The National Institute for Health and Clinical Excellence in the U.K. is opening public comment on the use of Smith & Nephew’s Exogen bone-healing device, according to a Bloomberg Businessweek report.

Advertisement

NICE makes recommendations to the government-run National Health Service on the cost-effectiveness of drugs or medical devices. NHS, in turn, uses these recommendations to decide whether to pay for use of these instruments.

More Articles on Orthopedic Devices:

Conmed’s Arthroscopic Business Line Sees 15% Growth

CareFusion Reports $968M 4Q Revenue, Up 3%

8 Spine Device Company 2Q Financial Reports

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.